跳至主要内容
临床试验/NCT05124847
NCT05124847已完成不适用

Time Restricted Eating as a Treatment for Pediatric Obesity

Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年9月27日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30
试验地点
2
主要终点
Carotid intima-media thickness

研究概览

简要总结

The main aim of the study is to collect preliminary information on the feasibility and efficacy of a time restricted eating intervention in Spanish children and adolescents with obesity and metabolic comorbidities. Two 8-week interventions will performed in a randomized crossover controlled design: a) reduction of the habitual eating window; b) standard care. Different measurements of body composition and cardiometabolic health markers will be performed along those weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Other
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
10 Years 至 15 Years(Child)
性别
All
接受健康志愿者

入选标准

  • Age between 10 and 15 at the start of the study.
  • Obesity defined according to the criteria of the World Health Organization (BMI≥p95) and at least one of the following conditions:
  • Hepatic steatosis confirmed by abdominal ultrasound in the previous 12 months.
  • Triglycerides> 150 mg/dl, confirmed in analytical determination in the 4 weeks prior to the start of the study.
  • HDL cholesterol <40 mg/dl, confirmed in analytical determination in the 4 weeks prior to the start of the study.
  • LDL cholesterol> 135 mg/dl, confirmed in analytical determination in the 4 weeks prior to the start of the study.
  • Insulin resistance, determined by elevated HOMA-IR confirmed by analytical determination in the 4 weeks prior to the start of the study.
  • Habitual eating window equal to or greater than 13 hours, with a response rate greater than 85%. Habitual eating window will be determined by self-registration during the screening process. Participants must properly record the habitual eating window in at least 12 of the 14 days that self-registration will be requested, and it must be equal to or greather than 13 hours at least 6 days a week.
  • Reporting to have maintained a stable weight and height status during the last two months (changes of less than 2 points in BMI (kg / m2)).
  • Agreement to participate in all phases and procedures of the study.

排除标准

  • Being diagnosed with an endocrine disorder, for example, diabetes mellitus under treatment with insulin or oral antidiabetics, thyroid disease, hypercortisolism, congenital adrenal hyperplasia.
  • Being diagnosed with a chronic digestive, rheumatological, neurological, cardiological, pneumological, autoimmune or infectious disease that affects energy metabolism.
  • Having undergone a surgical procedure that chronically alternates digestive or metabolic function.
  • Hypercholesterolemia requiring pharmacological treatment according to the Expert Consensus of the European Society of Arteriosclerosis specific to children.
  • Serum triglyceride concentration> 500 mg/dl.
  • Systolic or diastolic blood pressure values equal to or greater than the specific 95th percentile for age, sixth, and height, on 3 different occasions [42].
  • Hypertransaminasemia> 200 IU / L (5 times higher than the upper normal value in the laboratory), which would make it necessary to rule out other causes of liver disease.
  • Being diagnosed with an eating disorder or being at risk of developing these disorders, determined using the SCOFF questionnaire (two or more questions answered positively).
  • Presenting neurological alterations or chromosomopathies.
  • Consuming drugs or supplements that are likely to alter energy metabolism.
  • Being participating in a nutritional intervention or treatment of any kind, or having done so during the previous 3 months.
  • Having a demonstrable personal or professional relationship with any of the members of the investigation team.
  • Any other condition that in the opinion of the research team would contraindicate their participation.

结局指标

主要结局

Carotid intima-media thickness

时间窗: week 8

Continuous glucose monitoring

时间窗: From week 6 to week 8

Body weight

时间窗: week 8

Hepatic steatosis

时间窗: week 8

Length of eating window

时间窗: From week 0 to week 8

Body fat mass

时间窗: week 8

HOMA-IR

时间窗: week 8

Lipid profile

时间窗: week 8

次要结局

未报告次要终点

研究者

发起方
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验